Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
6.65 +0.14 / +2.15%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.65 0.00 / 0.00%
Volume: 2.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-69.7M10.4M-35.4M-42.6M
Total Other Cash Flow9.5M6.4M6.2M6.3M
Funds From Operations-57.4M18.8M-27.9M-35.6M
Funds From/For Other Operating Expenses-10.9M422.0K6.7M461.0K
Net Cash Flow - Operating Activities-46.4M18.4M-34.6M-36.1M
InvestingDecrease In Investments1.7M300.0K100.0K1.1M
Capital Expenditures-2.2M-226.0K-767.0K-137.0K
Fixed Asset Disposal0.000.00390.0K174.0K
Net Assets From Acquisitions
Net Cash Flow Investing-471.0K74.0K-277.0K3.0M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale3.9M3.7M23.7M40.1M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.000.000.0045.0K
Net Cash Flow - Financing3.9M3.7M23.7M40.1M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash-43.0M22.2M-11.3M7.0M

To view my watchlist

Not a member yet?

Sign up now for a free account